[Perspectives] Does global oncology need artificial intelligence?

Discussing the use of artificial intelligence (AI) for cancer care in low- and middle-income countries (LMICs) might seem like a paradox, but new technologies have sometimes reached LMICs faster than cancer drugs on the WHO Essential Medicines List. One example of AI already starting to take hold in cancer care in some LMICs is Watson for Oncology, developed by IBM in partnership with the Memorial Sloan Kettering Cancer Center (MSKCC, New York, NY, USA). Watson for Oncology is a cognitive computing system developed to provide treatment recommendations based on training it receives from published medical literature, publicly available treatment protocols, patient charts, test cases, and guidelines that have been selected by the experts from MSKCC.
Source: The Lancet Oncology - Category: Cancer & Oncology Authors: Tags: Perspectives Source Type: research